SEngine Precision Medicine Announces New Collaboration to Bring PARIS® Test to Patients with CNS Cancers

NEXT STORY
ALICE, a solution of Navigate360, Enhances Training and Launches Personal Safety Skills Curriculum
PREV STORY
AXIOM MEDICAL LEADS IN OSHA COVID COMPLIANCE EDUCATION AND DELIVERS END-TO-END SOLUTION
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

TESARO Announces Enrollment of First Patient in Phase 1 Clinical Trial of TSR-042

WALTHAM, Mass., March 29, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO), an oncology-focused biopharmaceutical ...

author_avatar
NASDAQ Market News

Progenics Pharmaceuticals Strengthens Management Team with Appointment of Huw Jones as Vice President, Commercial

author_avatar
NASDAQ Market News

Psychological Effects of Ovarian Cancer Often Overlooked and Can Have a Significant Impact on Patients

79% of patients felt uncomfortable raising psychological and emotional concerns during their consultations1Disease recurrence ...

author_avatar
NASDAQ Market News